LATEST NEWS
Solidarity with Ukraine
European private hospitals stand in solidarity with health professionals and hospitals in Ukraine. UEHP will follow the evolution of the needs and possible actions to be carried out to help the Ukrainian hospitals, which will be coordinated by our member, the Federation of Polish Private Hospitals (OSSP).
Contact: Dr Anna Leszczyszyn | ljerzyna@gmail com
tel. +48 661 300 262 | http://www.szpitale.org/
|
|
UEHP
European Private Hospitals Awards
Submit your project now to participate to the first-ever European Hospital Awards dedicated to the private hospital sector. Let your project be known!
Deadline for submission of projects is 31 March 2022
UEHP-FHP
E-conference « Europe en santé, le pari de l’attractivité »
|
In the context of the French Presidency of the European Union, and after two years of health crisis, health issues are central! At the initiative of the UEHP and the French Fédération of Private Hospitals (FHP), we invite you to our FHP-UEHP E-conference: "Europe and Health, the challenge of attractiveness". The conference will be held in French.
|
Wednesday 16 March 2022 from 9.30 am to 12 noon on the Zoom platform.
UEHP
UEHP General Assembly
We had a packed agenda, inspiring discussions, new projects and the presentation of the upcoming European Private Hospitals Awards. We also had the opportunity to hear from all our members about the situation of COVID-19 and vaccination in the different European countries. The pandemic is not over yet and private hospitals are still on the frontline in the fight against this invisible enemy.
Private hospitals can be proud of the work done these past years. It is time now to prepare for the next steps and all the members are needed to build the future.
We thank very much our French member FHP (Fédération de l’hospitalisation privée) for hosting us so warmly!
Thank you to FHP President Lamine Gharbi for his supportive words towards our work in Europe!
UEHP
UEHP President speaks at the Ministerial Conference on Citizenship, Ethics and Health Data
Wednesday February 2, I was invited as UEHP President to participate at a major European event organized in Paris by the French Health Ministry during the current French Presidency of the Council of the EU (PFUE). The theme was “Ministerial Conference on Citizenship, Ethics and Health Data” centered on “The European Union sets out a framework of trust as a basis for digital health”.
During this hybrid conference, prestigious speakers, including European Health Ministers and their representatives, debated the coordination project on ethics relating to health data in the EU27. Digital health allows for equitable access to quality health services and improves efficiency in hospitals and I was honored to be able to express and reaffirm the commitment of European Private Hospitals to support this collaborative process.
The EU Commission was represented by Sandra Gallina (European Commission, DG SANTE, Director General) and Roberto Viola (European Commission DG CNECT, Deputy Director General).
See this link with the event Press Release where you will find more detailed information, including documents on the EC engagement for the future of care regarding health data.
European Innovation Council (EIC)
Adoption of the work programme 2022
The European Commission adopted the 2022 work programme of the European Innovation Council (EIC). It opens funding opportunities worth over €1.7 billion in 2022 for breakthrough innovators to scale up and create new markets.
The three main funding schemes provided by EIC:
-
EIC Pathfinder - for multi-disciplinary research teams, worth €350 million, to undertake visionary research with the potential to lead to technology breakthroughs.
-
Research teams can apply for up to €3 or €4 million in grants. Calls will open on 1 March (Pathfinder Open) and 15 June (Pathfinder Challenges)
-
The bulk of the funding is awarded through open calls with no predefined thematic priorities, while €167 million is allocated to tackle six challenges: Carbon dioxide & nitrogen management and valorisation, mid-long term, systems-integrated energy storage, cardiogenomics, healthcare continuum technologies, DNA-based digital data storage and alternative quantum information processing, communication, and sensing.
-
EIC Transition - funding to turn research results into innovation opportunities, worth €131 million.
-
The calls will focus on results generated by EIC Pathfinder projects and European Research Council Proof of Concept projects, to mature the technologies and build a business case for specific applications. Consortia can apply for €2.5 million grants (or more if justified). Apply anytime from 1 March.
-
€60.5 million is allocated to tackle three Transition Challenges: Green digital devices for the future, process and system integration of clean energy technologies and RNA-based therapies and diagnostics for complex or rare genetic diseases.
-
EIC Accelerator - worth €1,16 billion, for start-ups and SMEs to develop and scale up high impact innovations with the potential to create new markets or disrupt existing ones.
-
It provides a unique blended finance combining equity (or quasi-equity such as convertible loans) between €0.5 million and €15 million through the EIC Fund, with grants of up to €2.5 million. Apply anytime.
-
Almost €537 million is earmarked for breakthrough innovations for the technologies for Open Strategic Autonomy and technologies for ‘Fit for 55’.
All projects of the European Innovation Council have access to Business Acceleration Services, which provides coaches, mentors and expertise, partnering opportunities with corporates, investors and others, and a range of other services and events.
EU
Healthier Together Initiative: call for best practices on non-communicable diseases
Non-communicable diseases represented 80% of the EU’s disease burden before the COVID-19 pandemic.
The European Commission is therefore calling for best practices focusing on prevention and management of non-communicable diseases: cardiovascular diseases, diabetes, chronic respiratory diseases, mental health and neurological disorders, and health determinants,
as part of the ‘Healthier together’ – EU Non-Communicable Diseases Initiative.
To support EU countries with reducing the burden of non-communicable diseases and improving citizens’ health, the European Commission invites governmental and non-governmental actors to submit proposals for
best practices via the EU Best Practice Portal by 15 May 2022 (midnight CET).
After this date, the European Commission will invite the owners of the top-ranked best practices to present them to representatives from EU countries. This may lead to joint/wider implementation across the EU under the EU funding programmes. The identification, dissemination and transfer of best practices is a priority for the Directorate General for Health and Food Safety with the aim of ensuring progress in health promotion and disease prevention throughout Europe.
Please note that the owners’ active involvement and collaboration is fundamental and expected for the top-ranked best practices.
For more information, please visit the full call for proposals: pb-portal (europa.eu)
EU
HERA first work plan with €1.3 billion for preparedness and response to health emergencies in 2022
Last 10 February, the new European Health Emergency Preparedness and Response Authority (HERA) presented its first annual work plan, which will have a budget of €1.3 billion in 2022 to prevent, prepare for and rapidly respond to cross-border health emergencies.
Following the adoption of the 2022 work plan by the HERA Board, HERA can now start implementing actions to strengthen preparedness and response capabilities within the EU, address vulnerabilities and strategic dependencies and contribute to reinforcing the global health emergency architecture.
As a key pillar of a strong European Health Union, HERA has set out a number of ambitious deliverables for 2022, both in the context of the ongoing COVID-19 response, and for preparedness for potential future health threats.
Prevent and prepare for future cross border health emergencies: In the “preparedness phase”, HERA will work closely with other EU and national health agencies, industry, research community, civil society and international partners to improve the EU's readiness for future health emergencies. Actions include:
- Procuring and stockpiling medical countermeasures for a series of public health threats with a budget of over €580 million;
- Releasing over €300 million to research and development of medical countermeasures and innovative technologies against emerging threats;
- Building a network of ever-warm manufacturing facilities that can be mobilised in case of emergency (EU FAB);
- Establishing a long term and large-scale EU platform for clinical trials and data platforms;
- Identifying three high-impact health threats, in addition to COVID-19, by the end of spring in close collaboration with Member States in the HERA Board, EU agencies, international partners and experts.
Detect future health threats: HERA will in addition carry out threat assessments and intelligence gathering, develop models to forecast an outbreak, and map out a response plan at EU level. Actions for 2022 include:
- Putting in place a state-of-the-art real-time health threat detection and intelligence system;
- Creating a dedicated IT platform for threat assessment and threat prioritisation.
Respond to health threats: In the context of the response to the COVID-19 pandemic, HERA's emergency response functions have already been activated. In the event of further cross-border public health emergencies at EU level, additional action will be taken, notably by activating emergency funding and launching mechanisms for monitoring, new targeted development, procurement and purchase of medical countermeasures and raw materials. Ongoing actions include:
- Ensuring the timely provision of COVID-19 vaccines to EU Member States, including variant-adapted vaccines if needed;
- Procurement of COVID-19 therapeutics for EU Member States;
- Scaling up national capacities for the detection and scientific assessment of variants;
- Ensuring delivery of vaccines across the world.
International
World Cancer Day
|
World Cancer Day is held every 4 February and it is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education and catalysing personal, collective and government action, we are all working together to reimagine a world where millions of preventable cancer deaths are saved and access to life-saving cancer treatment and care is equitable for all - no matter who you are or where you live.
|
Created in 2000, World Cancer Day has grown into a positive movement for everyone, everywhere to unite under one voice to face one of our greatest challenges in history.
Each year, hundreds of activities and events take place around the world, gathering communities, organisations and individuals in schools, businesses, hospitals, marketplaces, parks, community halls, places of worship - in the streets and online - acting as a powerful reminder that we all have a role to play in reducing the global impact of cancer.
While we live in a time of awe-inspiring advancements in cancer prevention, diagnosis and treatment, many of us who seek cancer care hit barriers at every turn. Income, education, geographical location and discrimination based on ethnicity, gender, sexual orientation, age, disability and lifestyle are just a few of the factors that can negatively affect care.
So this year's World Cancer Day's theme, “Close the Care Gap”, is all about raising awareness of this equity gap that affects almost everyone, in high as well as low- and middle-income countries, and is costing lives.
Portugal
World Hospital Congress 2023
|
The International Hospital Federation (IHF) has announced that the 46th World Hospital Congress (WHC) will be held at the Lisbon Congress Centre (Portugal) on 25–27 October 2023.
This is a great event in which more than 1000 world specialists will debate in Lisbon the future of hospitals and health systems from the perspective of citizens, efficiency, innovation and sustainability.
|
The decision of the International Hospital Federation (IHF) follows an application submitted by the Portuguese Association of Private Hospitals (APHP), the Portuguese Association of Hospital Development (APDH) and the Portuguese Association of Hospital Administrators (APAH).
It was a truly national joint proposal through which aspired to place Lisbon at the centre of the debates on excellence in care delivery. All hospitals, whether public or private, face major challenges and are an essential part of the future of health systems.
The three associations will work together, along with the IHF, to host this global event.
Save the date!
The announcement is now live on the following IHF channels.
Website:
Social media:
UEHP Partner
Ernst & Young (EY)
Christian Egle, GSA Health Sector Leader
E&Y is partner of the European Private Hospitals Awards 2022
|
What is EY's involvement in the European health sector?
Thinking along the patient’s journey, EY works with all different stakeholders within the European healthcare system. One key element is EY’s strong connectivity within the sector which enables us to assemble the right teams, share leading practices across Europe and address healthcare organization’s needs, whatever location they are active in.
|
In order to achieve a stronger cross-border collaboration, the EY health sector is today organized as a one structure within Europe. This is a key added value for our clients. Our focus in Europe is centered around Digital and Emerging Technologies, Innovation, Customer & Employee Experience as well as Sustainability. We are committed to developing industry focused solutions that help health care organizations anticipate industry trends and create competitive advantage. Our solutions ensure the delivery of better health outcomes and personalized care. Today, we are stepping into the age of “Health Experience”. Companies will have the opportunity to build richer and more meaningful relationships with all parties in the value chain. These relationships will no doubt strengthen customer loyalties and trust – and digital technologies will provide the tools. We are staying close to our clients such as at ERASMUS or Karolinska to help them stay ahead of the trend.
Mergers and Acquisitions (M&A) = what is your involvement, and do you accompany projects with a European dimension in Health (no commercial secret but more a global reading of the market)? And what are the growth sectors: biology, imaging, providers, etc.?
At EY our M&A activities in Europe for the health sector have a focus on advising private equity funds within the provider space. For instance, in Germany we have a strong focus in this area due to the recently increased PE’s attraction to the German outpatient market. We also cover a wider European focus by advising on inorganic growth strategies for cross border acquisitions.
On a transactions perspective we also have been involved in several health projects including Imaging, Nursing Homes, Hospital, Medical Laboratories and Pharmaceutical companies.
In Portugal there is a clear tendency for growth of the Hospital segment, with space for consolidation. The Medical laboratories market is still considerably growing, in line with the pandemic. There is a strong appetite for investment in this segment. One segment that has seen a strong expansion is the Wellness segment, especially for dietary supplements, that are arousing great interest from investors.
Overall, the horizontal growth of the Health sector maintains a growth trend where players are looking to invest in more health services in order to widen the specter of care services and to create a strong cross selling synergy between different players.
Do you think that the European health sector will be different in terms of organization after the COVID-19 crisis?
COVID-19 has accelerated the move towards care delivery outside the four walls of a traditional health system. Meeting these expectations will mean expanding the traditional definitions of innovation in health care, which historically have focused on the safety, effectiveness or efficiency of care. Of course, these will always remain important, but patients and providers alike now expect and demand more: a more seamless health experience, delivered where and when it is wanted. For instance, due to COVID-19 health providers are required to reconsider their integrated strategies, redefine existing partnerships and prioritize innovation as a pathway to winning in the market. In fact, the pandemic has accelerated previous trends driven by economic and demographic shifts, widening competitive landscape, accelerating cost pressures, digitization and consumerism. These trends impact not only health providers, but all the stakeholders within healthcare, with payers probably being one of the stakeholders that is being more pressed to adjust faster. Questions such as how they will pay for health care and how quickly they will be able to adapt contracts and payment methods to unexpected situations such as pandemics and hospitalization at home make new business models and investments necessary.
That is why, at EY we believe the European Health Sector will be not only different, but better in the years to come, provided we can all rise to the challenge of fostering these changes. The technology needed is already here and the crisis has made clear the need for changes. We should not ignore it.
How can we encourage cooperation in health between Member States? Do you see a need to encourage the European dimension of organizations (exchanges of experience, critical size, best practices, etc.)?
For EY cooperation is the cornerstone of all important initiatives. Be it between different types of stakeholders, different member states or different teams within the same project it is always invaluable. In the case of healthcare, cooperation is even more indispensable because one missed communication might mean the loss of human lives. Even though Europe holds many different health systems, the pandemic has proven to us that Europe is only as strong as its weaker link and that the need for information to flow across countries at the speed of light is an essential asset. Therefore, it is essential to promote cooperation in all of its forms: sharing of common standards, experiences, best practices, data, etc. and ensure that together we are building a more equitable and efficient healthcare system for all European citizens. Here are some examples we can elaborate on: open data platforms, smart health solutions, the use of clinical and genetic data to promote personalized health and reduce costs, etc.
You are helping to organize the European Private Hospital Awards: what are your expectations for this event?
At EY we are proud to support events such as this one, because we strongly believe it is our goal to help build a better and more sustainable world and in that sense all experiences that help promote the sharing and the advancement of the best healthcare initiatives within Europe, especially in the past years, should be valued and fostered. In fact, if there is something the world has proven to us in recent history, it is the need for countries to come together and take advantage of the best practices wherever they may come from and spread them across countries. Acting accordingly, we are growing our Healthcare-Team in this region by size and depth so we can bring new insights and content to clients. Supporting this event is also an opportunity for us to learn from European hospitals about future challenges and risks.
Finally, but not least important, at EY we are also strong believers in rewarding good work, and we are convinced that healthcare providers are one of the most deserving stakeholder groups to be rewarded for their unbelievable job in the past years. In this perspective it is our expectation that the European Private Hospital Awards will be a unique opportunity to recognize private health providers across Europe, and to keep Health in the economic and social agenda in such atypical times.
|